Ischemic Stroke in the Course of COVID-19 in a 16-Year-Old Boy

Bartłomiej Syzdoł1, Anna Maria Rzewuska1, Wiktoria Sielwanowska1

  • 1Students' Scientific Society at the Department of Pediatric Radiology, Medical University of Lublin, 20-059 Lublin, Poland.

PubMed

Insights

Multisystem inflammatory syndrome in children (MISC) is a rare complication of SARS-CoV-2 infection. This case highlights a MISC patient who developed an ischemic stroke, emphasizing the need for vigilance in pediatric cases.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Neurology

Background:

  • The SARS-CoV-2 virus continues to evolve, posing ongoing public health risks.
  • Multisystem inflammatory syndrome in children (MISC) is a rare but serious complication of COVID-19, affecting less than 1% of pediatric cases.
  • MISC carries risks of life-threatening thromboembolic and cardiac complications.

Observation:

  • A 16-year-old boy presented with fever, conjunctivitis, gastrointestinal symptoms, and general weakness.
  • The patient's mother had a positive SARS-CoV-2 test.
  • During hospitalization, the patient developed neurological symptoms including dysarthria and right-sided weakness.

Findings:

  • Laboratory tests and clinical presentation were consistent with MISC.
  • Magnetic resonance imaging revealed changes indicative of an ischemic stroke.
  • The patient received anticoagulant therapy, antipyretics, steroids, and IVIG.

Implications:

  • This case underscores the potential for severe thrombotic complications, such as ischemic stroke, in children with MISC.
  • Further research is necessary to understand and manage thrombotic risks associated with SARS-CoV-2 infection in pediatric populations.
  • Healthcare providers should maintain heightened vigilance for neurological and thrombotic complications in children presenting with MISC symptoms.